[HTML][HTML] Role of PI3K/AKT pathway in cancer: the framework of malignant behavior

N Jiang, Q Dai, X Su, J Fu, X Feng, J Peng - Molecular biology reports, 2020 - Springer
Given that the PI3K/AKT pathway has manifested its compelling influence on multiple
cellular process, we further review the roles of hyperactivation of PI3K/AKT pathway in …

Role of RUNX1 in hematological malignancies

R Sood, Y Kamikubo, P Liu - … Journal of the American Society of …, 2017 - ashpublications.org
RUNX1 is a member of the core-binding factor family of transcription factors and is
indispensable for the establishment of definitive hematopoiesis in vertebrates. RUNX1 is …

[HTML][HTML] Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia

Y Liu, Z Cheng, Y Pang, L Cui, T Qian, L Quan… - Journal of hematology & …, 2019 - Springer
Acute myeloid leukemia (AML) is a malignant tumor of the immature myeloid hematopoietic
cells in the bone marrow (BM). It is a highly heterogeneous disease, with rising morbidity …

Molecular biomarkers in acute myeloid leukemia

J Prada-Arismendy, JC Arroyave, S Röthlisberger - Blood reviews, 2017 - Elsevier
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The
pathophysiology of this disease is just beginning to be understood at the cellular and …

Targeting PI3K/AKT/mTOR network for treatment of leukemia

J Bertacchini, N Heidari, L Mediani, S Capitani… - Cellular and molecular …, 2015 - Springer
Objective Increased activity of PI3K/AKT/mTOR pathway has been observed in a huge
number of malignancies. This pathway can function as a prosurvival factor in leukemia stem …

MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts

JA Wallace, RM O'Connell - … Journal of the American Society of …, 2017 - ashpublications.org
Acute myeloid leukemia (AML) is a deadly hematologic malignancy characterized by the
uncontrolled growth of immature myeloid cells. Over the past several decades, we have …

MicroRNA-193a-3p and-5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway

T Yu, J Li, M Yan, L Liu, H Lin, F Zhao, L Sun, Y Zhang… - Oncogene, 2015 - nature.com
The metastatic cascade is a complex and multistep process with many potential barriers.
Recent evidence has shown that microRNAs (miRNAs) are involved in carcinogenesis and …

[HTML][HTML] Tumor suppressor microRNAs contribute to the regulation of PD-L1 expression in malignant pleural mesothelioma

SC Kao, YY Cheng, M Williams, MB Kirschner… - Journal of Thoracic …, 2017 - Elsevier
Introduction The upregulation of programmed death ligand 1 (PD-L1) is found in many
cancers and contributes to evasion of the host's immune defense. In malignant pleural …

[HTML][HTML] Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

A Zhao, H Zhou, J Yang, M Li, T Niu - Signal Transduction and Targeted …, 2023 - nature.com
Hematologic malignancies are one of the most common cancers, and the incidence has
been rising in recent decades. The clinical and molecular features of hematologic …

An update on the molecular pathogenesis and potential therapeutic targeting of AML with t(8;21)(q22;q22.1);RUNX1-RUNX1T1

S Al-Harbi, M Aljurf, M Mohty, F Almohareb… - Blood …, 2020 - ashpublications.org
Acute myeloid leukemia (AML) with t (8; 21)(q22; q22. 1); RUNX1-RUNX1T1, one of the core-
binding factor leukemias, is one of the most common subtypes of AML with recurrent genetic …